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Neurofeedback for Chronic Pain
Kajal Patel, Manoj Sivan, James Henshaw and Anthony Jones
Abstract
Neurofeedback is a novel neuromodulatory therapy where individuals are given 
real-time feedback regarding their brain neurophysiological signals in order to 
increase volitional control over their brain activity. Such biofeedback platform can 
be used to increase an individual’s resilience to pain as chronic pain has been associ-
ated with abnormal central processing of ascending pain signals. Neurofeedback 
can be provided based on electroencephalogram (EEG) or functional magnetic 
resonance imaging (fMRI) recordings of an individual. Target brain rhythms 
commonly used in EEG neurofeedback for chronic pain include theta, alpha, beta 
and sensorimotor rhythms. Such training has not only been shown to improve 
pain in a variety of pain conditions such as central neuropathic pain, fibromyalgia, 
traumatic brain injury and chemotherapy induced peripheral neuropathy, but 
has also been shown to improve pain associated symptoms such as sleep, fatigue, 
depression and anxiety. Adverse events associated with neurofeedback training 
are often self-limited and resolve with decreased frequency of training. Provision 
of such training has also been explored in the home setting whereby individu-
als have been encouraged to practice this as and when required with promising 
results. Therefore, neurofeedback has the potential to provide low-cost yet holistic 
approach to the management of chronic pain.
Keywords: neurofeedback, EEG biofeedback, fMRI biofeedback, chronic pain, pain, 
fatigue, depression, anxiety, sleep
1. Introduction
Neurofeedback [1, 2] is a smart biofeedback platform which provides real-time 
feedback to individuals about their neurophysiological signals in order to achieve 
brain activity associated with therapeutic benefit. Brain activity of an individual is 
measured continuously using an EEG system during the course of neurofeedback 
training and parameters describing neurophysiological signals such as alpha power 
or peak alpha frequency are calculated in real-time [3]. These calculated features 
of ongoing brain activity are then presented to the individual either in an audio 
or visual form [3]. The idea behind this is that through repeated provision of such 
feedback, the individual gains an awareness of their current brain state and can 
identify different mental strategies which help them achieve the desired brain state 
[4]. Once the individual identifies strategies which work for them, they can keep 
practicing them over the course of multiple sessions with the final aim of being able 
to implement these strategies independent of a neurofeedback session.
Neurofeedback has already been investigated extensively for the management 
of several neuropsychiatric conditions [5] such as Attention Deficit Hyperactivity 
Disorder (ADHD) [6], depression and anxiety [7], cognition [8] and stroke 
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rehabilitation [9] for example. Being able to target brain signals through neurofeed-
back can be of great benefit in conditions such as chronic pain. This is because the 
perception of chronic pain depends on how multiple regions of the brain process 
the ascending pain signals [10, 11]. Such central processing of incoming pain 
signals has been shown to be different in chronic pain patients compared to healthy 
participants by a number of studies [12–14]. Considering the brain plays such an 
important in the development and maintenance of chronic pain state, being able 
to target changes in the neurophysiological signal which reflect such brain activity 
using a novel therapy such as neurofeedback is of great interest.
The field of neurofeedback therapy for chronic pain is rapidly developing. 
Several studies have been performed on a range of medical conditions over the last 
decade [15]. The current studies are highly heterogenous with a number of varia-
tions in neurofeedback protocol and delivery [15, 16]. This chapter aims to give an 
overview of the neurophysiological changes observed in chronic pain and how these 
have been targeted by different neurofeedback studies. We also discuss the different 
aspects of neurofeedback protocols which have been used so far and the outcomes 
of these studies in terms of reduction in pain and pain associated symptoms.
2. Neural pathways underlying pain perception
Our understanding of the neuroscience underlying pain has evolved signifi-
cantly over time. Neural pathways involved in pain perception have been shown in 
Figure 1. One of the earliest theories explaining pain was the “specificity theory” 
(Figure 1: Red pathway). According to this theory, pain is experienced when an 
injury to a particular part of the body leads to signals being relayed via nocicep-
tive neurons to the “pain center” [17]. The brain was considered to be a “passive 
recipient of sensory information” [17].
Figure 1. 
Neural pathways underlying pain perception proposed by different pain theories.
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One of the landmark theories which was highly influential in changing this prior 
understanding of pain was the Gate Control Theory by Melzack and Wall (1965) 
[18] (Figure 1: Blue pathway). This theory proposed that several neurons in the 
spinal cord, such as large fibers carrying touch and vibration sensations as well as 
interneurons in substantia gelatinosa of the dorsal horn, modulate the incoming 
signals from the site of pain, thereby influencing the final signal which is transmit-
ted to the brain for processing.
Since then, advances in neuroimaging has revealed that in addition to neu-
ral pathways in the spinal cord, several cortical structures are also involved in 
modulating pain perception [19, 20] (Figure 1: Purple pathway). Some of the 
areas which have been reported to be involved include anterior cingulate gyrus, 
somatosensory cortex, insular cortex, thalamus and prefrontal cortex [19]. These 
findings suggest that there is not a single “pain centre”. Instead, pain is processed 
by a “pain matrix” connecting different parts of the brain, thereby, reinforcing 
the idea that pain perception is a result of several sensory, affective and cognitive 
processes [10, 11]. Therefore, pain experienced by an individual is an integra-
tion of the current information about the painful sensory stimulation and prior 
information from previous experiences which influence the emotions, anxiety, 
attention and expectations of the individual about the pain [21].
Different areas of the cortex constituting the pain matrix project onto the 
hypothalamus and amygdala, which then give rise to both descending inhibitory 
pathways and descending facilitatory pathways [21, 22]. These descending path-
ways directly project onto the dorsal horn of the spinal cord where gating of pain 
is occurring, therefore, influence the signals which are relayed up the ascending 
pathways [21, 22]. This process is known as top-down modulation of pain [23].
In summary, the pain perceived by an individual is an integration of how 
different parts of the cortex process the ascending pain signals as well as how 
the activity of these cortical and subcortical structures influence the ascending 
pain signals via descending pathways [17, 21, 24]. With the discovery of these 
higher-order processes which influence pain perception, several neuromodula-
tory therapies such as neurofeedback (NFB), hypnosis and meditation, have been 
explored with the potential of controlling pain by influencing this supraspinal 
cortical processing of pain [25].
3. Brain rhythms associated with chronic pain
Generally, the EEG oscillations are categorized based on their frequency into 
theta (4–7 Hz), alpha (8–12 Hz), low beta or beta1 (15–20 Hz) and high beta or beta2 
(22–30 Hz) [26–29]. Another oscillation which is widely investigated in the field of 
neuromodulation is sensorimotor rhythm (SMR). SMR refers to oscillations in the 
12–15 Hz range which appear in spindle-like pattern over the sensorimotor cortex 
during idling of the motor cortex [30, 31]. Motor execution or motor imagery which 
activates the motor cortex leads to a decrease in the SMR activity [31].
Each of these brain rhythms is associated with a specific cognitive state. For 
instance, whilst alpha waves have been associated with a relaxed state, beta waves 
are associated with wakefulness and a state of engagement in task. Theta waves have 
been associated with drowsiness [27, 32].
Patients with chronic pain have differences in their resting-state brain (EEG) 
oscillations from healthy individuals. An example of a chronic pain condition which 
has been extensively investigated for identification of EEG correlates of chronic 
pain has been spinal cord injury (SCI). A study by Sarnthein et al. [12] showed that 
SCI patients with central neuropathic pain had increased activity of theta and beta 
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oscillations compared to healthy individuals. These findings were confirmed by 
another study [13] which observed similar increases in theta and beta activity, but 
in addition, also identified lower levels of alpha activity in this patient population. 
This association between chronic pain and EEG changes was further strengthened 
when Jensen et al. [33] demonstrated that even within a group of patients with 
spinal cord injury, individuals with central neuropathic pain had higher theta and 
lower alpha activity than patients with spinal cord injury but no chronic pain.
These patterns of EEG have also been reported in other chronic pain conditions. 
For instance, patients with migraine have higher theta and delta power compared 
to healthy controls [14]. Patients with fibromyalgia have been shown to have higher 
theta activity with sources estimated to be in the left dorsolateral prefrontal and 
orbitofrontal cortex, higher beta and gamma activity with sources estimated to be 
in the insular, primary motor and primary and secondary somatosensory cortices 
and slowing of the dominant alpha peak [34].
Identification of such neurophysiological correlates of chronic pain is important 
as it not only provides the necessary feedback signal to increase voluntary control 
in therapies such as neurofeedback, but also allows monitoring the efficacy of the 
therapy in modulating the neurophysiological processes targeted by the therapy.
4. Neurofeedback training protocols
There are two key modalities which have been used to provide neurofeedback – 
EEG neurofeedback and fMRI neurofeedback. Whilst EEG neurofeedback provides 
feedback based on the neurophysiological signals recorded through an EEG system, 
fMRI neurofeedback provides feedback based on the degree of activation of a par-
ticular region of the brain detected using fMRI imaging in real time [35]. Hence it is 
inevitable that there is some lag between the activation and signal detection in fMRI 
neurofeedback which happens almost instantaneously in EEG neurofeedback [35].
Evidence regarding efficacy of fMRI neurofeedback in pain is limited under-
standably due to the increased difficulties and expenses associated with this form. 
The common region of interest which has been targeted in fMRI studies has been 
rostral anterior cingulate gyrus (rACC), whereby increased activity of rACC, mea-
sured through detecting an increase in blood oxygen level dependent signal from 
the region, has been associated with pain reduction [36, 37]. However, these studies 
have been severely limited in terms of number of sessions [37, 38], therefore the full 
benefit of the neurofeedback which occurs over the course of several sessions has 
not been explored yet in fMRI neurofeedback for chronic pain.
A number of brain rhythms have been targeted by EEG neurofeedback in order 
to increase resilience to pain (Table 1). The commonly targeted rhythms include 
theta (4–7 Hz), alpha (8–13 Hz), beta (14–30 Hz) and sensorimotor (12–15 Hz over 
the sensorimotor area) [17]. However, the change desired in each of these rhythms 
varies. Whilst pain reduction has been associated with an increase in the power 
of alpha and sensorimotor rhythms, contrastingly, a decrease in theta and beta 
rhythms have been associated with pain relief [17]. However, very few studies target 
these signals in isolation [20, 39]. More often studies target multiple signals at the 
same time, whereby patients are either shown each rhythm individually at the same 
time or they are shown feedback based on the ratio of two such signals [40–43].
In general, neurofeedback sessions tend to be 30–45 minutes long and patients 
are offered 20–40 sessions [15]. The frequency of these sessions ranges from one 
to five times a week, but studies which administered more frequent sessions have 
reported greater pain relief. Commonly used electrodes for providing feedback 
include C3, C4, Cz, T3, T4, FP1, P3 and P4 [15].
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Feedback has been provided in a range of ways. Auditory feedback has been 
mainly in the form of changing volume of sound, whereby, achievement of signal 
has been associated with an increase in the volume heard [44]. Visual feedback 
used has been more varied (Figure 2). Some studies use simple bars to show the 
feedback, whereby the height of the bar is proportional to the intensity of the signal 
[45]. Other studies have changed the color of the bar on achievement of signal such 
that when the threshold is met, the color turns green, otherwise it remains red [43]. 
Some studies have tried to engage the users through the idea of games whereby the 
width of a river increases as the intensity of signal increases for instance [41, 46]. 
Therefore, feedback has been provided in a range of ways. Another form of stimula-
tion which can be explored in the context of neurofeedback is tactile stimulation. 
Some studies have even combined two forms of stimuli such as visual and auditory 
whereby patient is shown an angry and shouting patient [36]. In order to calm the 
patient, the individual has to achieve the desired changes in the brain rhythms.
5. Efficacy of neurofeedback in management of chronic pain
Several neurofeedback studies have shown pain reduction following neuro-
feedback. Key randomized controlled trials in the field have been summarized in 
Table 2. Reduction in pain has been reported across several pain conditions such as 
Fibromyalgia [27, 29, 36, 41], Central Neuropathic Pain in Paraplegic patients  
[28, 43, 47–49], Traumatic Brain Injury [39, 50], Chemotherapy-Induced Peripheral 
Neuropathy [51], Primary Headache [52], Complex Regional Pain Syndrome Type I 
[53], Post-Herpetic Neuralgia [37] and chronic lower back pain [54]. There is a wide 
Brain rhythm Frequency Desired change
Theta 4–7 Hz Decrease in power
Alpha 8–13 Hz Increase in power
Beta 14–30 Hz Decrease in power
Sensorimotor rhythm 12–15 Hz
Over sensorimotor cortex
Increase in power
Table 1. 
Neurofeedback targets [17].
Figure 2. 
Schematic representation of visual stimulus provided in different neurofeedback studies.
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range of pain reduction reported which can range from an average of 6–82% reduc-
tion in pain intensity [15]. A recent systematic review published showed that ten 
out of twenty-one studies published in the field reported a pain reduction of greater 
than 30% which is considered to be clinically significant reduction [15].
Such variability in the degree of pain reduction could be due to a number of 
aspects of the neurofeedback protocol ranging from number of sessions, frequency 
of sessions, target frequencies and electrodes used for feedback, for example. The 
neurofeedback studies conducted so far have been highly variable on more than one 
of these aspects [15, 16], making comparison of results across studies impossible. 
Therefore, it is difficult to determine which of these parameters is responsible for 
the difference or how to best optimize each of these aspects of the training.
Most of the neurofeedback studies have measured changes in pain immediately 
following neurofeedback [39, 43, 52, 55, 56]. Furthermore, pain reduction has 
been reported to be sustained even at follow up of 3–6 months after completion of 
neurofeedback training [28, 36, 41, 49–51, 54]. However, these studies do not report 
whether the corresponding change in brain rhythm which were measured following 
completion of training were also sustained at long-term follow-up. We do not know 
the length of time for which the effect of neurofeedback on brain rhythms is sus-
tained. Interestingly, one study reported that although pain reduction did not occur 
immediately following completion of the training course, there was improvement 
in pain at follow-up [36]. This could suggest that perhaps NFB could lead to changes 
in the underlying brain networks which occurs over a longer period of time but can 
be sustained for longer duration. These results provide the preliminary evidence for 
potential of neurofeedback for providing analgesia in chronic pain.
It has been shown that neurofeedback not only leads to reduction in pain but 
leads to improvement in a number of pain associated symptoms such as depression 
Study Chronic pain 
condition
Target brain 
oscillation
% Pain 
reduction
Pain associated 
symptoms reported to 
improve following NFB
Goldway et al. 
(2019) [36]
Fibromyalgia ↓Amygdala 
activation 
(fMRI)
7% REM latency
Sleep quality
Prinsloo et al. 
(2018) [50]
Chemotherapy-
induced peripheral 
neuropathy
↑Alpha
↓Beta
45% Fatigue
Cancer-related 
symptoms
Physical functioning
Quality of life
Guan et al. 
(2015) [37]
Post-herpetic 
Neuralgia
↓rACC activity 
(fMRI)
64% None studied
Farahani et al. 
(2014) [45]
Primary headache ↑SMR
↓Theta
↓Beta
19% None studied
Caro et al. 
(2011) [29]
Fibromyalgia ↑SMR
↓Theta
↓Beta
39% Fatigue
Kayiran et al. 
(2010) [40]
Fibromyalgia ↑SMR
↓Theta
↓Beta
82% Fatigue
Depression
Anxiety
Social functioning
Physical functioning
Table 2. 
Randomized controlled trials investigating role of neurofeedback in chronic pain conditions.
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[27, 39, 41, 54, 57–60], anxiety [27, 41, 54, 57, 59], fatigue [27, 29, 41, 49, 51], and 
sleep [36, 39, 49–51, 57]. These symptoms have been known to co-exist with pain in 
chronic pain conditions and also known to exacerbate the individual’s pain on a day-
to-day basis [61–63]. Therefore, by being able to target these symptoms along with 
pain, neurofeedback has the potential to holistically improve the well-being of these 
individuals. A summary of different symptoms which have been shown to improve 
following neurofeedback have been shown in Figure 3.
Current neurofeedback studies have a number of limitations. There are currently 
only seven controlled trials in the field [29, 41, 47, 51, 52, 64, 65], of which only 
one trial is of high quality [65]. Most of the trials lack appropriate blinding as the 
control group are often patients on other pain medications [29, 66]. This makes the 
blinding of patient difficult and could lead to patient’s belief in treatment affecting 
the results. Only two studies have implemented sham neurofeedback [36, 37].
The best sham treatment to offer is debatable. One would argue that patients 
could be shown the feedback signal from another region of the brain. But this 
might not be best as it might be the case that another region which is used for 
feedback might be the undiscovered part of the pain matrix. Another way to pro-
vide sham feedback would be to show the individual the recording from another 
participant or their own recording in a reverse order. Whilst this might be a true 
sham condition as the feedback shown to the individual would be independent 
of the individual’s brain activity, it might mean that the patients find no relief of 
symptoms and discover that it is a sham treatment. Either way, such sham neuro-
feedback needs to be implemented by more studies in order to truly understand 
whether the pain reduction reported in these individuals is due to underlying 
changes in neuronal networks.
Whilst we have learnt a lot about neurofeedback over the past decade, there is 
still a lot which is unknown about this technique. Neurofeedback differs from other 
neuromodulatory techniques such entrainment and transcranial magnetic stimula-
tion in that neurofeedback involves active involvement of the individuals in changing 
Figure 3. 
Schematic representation of pain and pain associated symptoms in chronic pain syndromes.
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the brain oscillations, as opposed to passive reception of stimulation [5]. We do 
not know which of these is a more efficient technique to alter brain oscillations yet. 
Furthermore, it is also unknown what mental strategies in particular are associated 
with changes in brain oscillations seen in the studies so far. Some of the common 
instructions given to patients undergoing training involve asking them to stay 
relaxed, imagining happy moments, revisiting happy memories and thinking about 
favorite family member or friends. However, none of the studies so far document 
which of these strategies actual work for the patients. Therefore, further qualitative 
studies are required to see what patients have been using to actively change their 
brain oscillations during neurofeedback in order to provide more focused instruc-
tions to patients undergoing training. Furthermore, studies should aim to analyze the 
correlation between neurophysiological signal and pain reduction rather than solely 
focusing on the behavioral outcomes [29, 41, 47, 51, 52, 64, 65]. Establishing such cor-
relation between behavioral change and changes in neurophysiological signal is key to 
understanding whether the pain relief is truly due to neurofeedback.
In addition to this, there is also a possibility that once the patients have been able 
to identify the mental strategy which allows them to achieve the desired brain state 
and practice in the neurofeedback setting for a number a sessions, they might be 
able to implement such mental strategies without the ongoing EEG signal feedback. 
It is not clear if this possible or how long it might take for an individual to become 
independent of the EEG feedback and still receive pain relief.
The current neurofeedback studies are highly heterogenous. It is unclear which 
brain regions, oscillations, feedback form or training length is required to optimize 
the improvement in pain. More studies are required comparing one aspect of the 
neurofeedback training program at once in order to determine which of these 
parameters provide the most therapeutic benefit.
Another area of uncertainty is the efficacy of neurofeedback in different pain 
conditions. Studies so far have shown that all chronic pain condition report pain 
reduction to some degree following neurofeedback. However, it is not known 
whether neurofeedback is better for some chronic pain conditions than others. It 
might be the case that neuronal changes seen following neurofeedback is linked to 
central sensitization only, in which case several chronic pain conditions may benefit 
from it equally as many pain conditions have this as the underlying pathology. 
However, we do not know whether it is equally as good at treating nociceptive pain 
as seen in conditions such as arthritis.
Furthermore, the role that neurofeedback will play in pain management in the 
future is not clear [16]. It is not clear whether it has the true potential to substitute 
pharmacological agents completely. It might be the case that it might reduce the 
escalation of opioid usage in this patient cohort. Hence further studies are needed 
to determine the maximum potential of this form of therapy.
6. Adverse effects associated with Neurofeedback
In general, neurofeedback is well tolerated with a minority of patients experienc-
ing mild adverse events. These adverse events are often self-limiting and tend to be 
controlled by decreasing the frequency of training [43, 48]. Adverse events seen 
in neurofeedback studies seem to be more common in certain patient groups than 
others. For instance, some individuals with spinal cord injury and central neuropathic 
pain have reported some hypersensitivity of soles of the feet due to recovery of pro-
prioception or spasms of the lower limb, [28, 48]. Patients with traumatic brain injury 
have reported an increase in nausea and the intensity of their headaches [39, 67]. It is 
difficult to confirm that these side-effects are due to NFB as these reported symptoms 
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are often seen in these conditions irrespective of provision of neurofeedback therapy. 
Overall, NFB is safe and well-tolerated in majority of patients in most clinical studies.
7. Delivery of home-based neurofeedback therapy
Neurofeedback has also been delivered in the home setting by a few recent 
studies [43, 48]. This can be achieved through the use of a headset which records 
activity from one single electrode, such as C4 [43, 48] or FP1 [39] and makes use of 
an app on tablets to analyze and showcase feedback to the individual [28, 48]. Such 
systems have been implemented in patients with central neuropathic pain [43, 48] 
as well as traumatic brain injury [39]. Patients could practice neurofeedback for 
5- or 10-minutes sessions as and when they wanted.
These studies have shown some promising results. With further expansion of this 
technology, it might be possible for individuals to benefit from neurofeedback at their 
home as and when required as patients have on average used neurofeedback 3–40 
times over the course of 2–3 months in these studies [43, 48]. Two of these studies have 
reported around 33% reduction in pain [43, 48] whereas one of them reported 16% 
reduction in pain [39] on average in participants who tried these home-based systems.
One of these studies also performed qualitative research on user experience 
following such home-based systems [43]. Overall, it was reported that the patient 
satisfaction score was high when measured using QUESB (Quebec User Evaluation of 
Satisfaction Questionnaire). According to the patients, the key factors which affected 
the frequency of their use of the home-based device were their health state, availability 
of free time and their intensity of pain. Patients also put effectiveness, ease of use and 
comfort as their main priority when using any such home-based device. Hence whilst 
the current home-based technology used in this study showed that it could record the 
data with decent quality, it also highlighted that patients wanted technology which 
was able to provide neurofeedback wirelessly using headset and smart device as well as 
collect information from the scalp without the use of gel to connect electrodes.
Being able to do this on a regular basis would also increase the efficacy of the 
therapy and patients might be able to use neurofeedback in addition to or instead 
of commonly used pharmacological agents which are associated with significant 
adverse effect profiles. Therefore, home-based neurofeedback can act as a novel 
treatment option to provide pain relief to patients with much fewer side effects than 
current pharmacological agents [68].
8. Conclusions
Neurofeedback is a newly emerging technique which can be used to achieve brain 
states associated with increased resilience to pain. The results so far have been very 
promising not only in terms of improvement in chronic pain, where as many as half of 
the studies in the field have shown clinically significant reduction in clinical pain fol-
lowing neurofeedback, but also in terms of improvement in pain associated symptoms 
such as fatigue, depression, anxiety and sleep which have also been reported to improve 
with neurofeedback. Being able to target all of these co-morbidities holistically using 
neurofeedback is key for the overall improvement in the well-being of chronic pain 
patients because these factors are often interlinked and aggravate each other.
There is still a lot of work that needs to be done. Different aspects of training 
protocols, such as target signal, number of sessions, length of sessions and scalp 
region of interest, need to be optimized in order to identify parameters which lead 
not only to successful modulation of the brain activity but also a corresponding 
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change in pain signals. Currently, it is not clear what neurofeedback protocol brings 
about maximum pain relief for patients.
Furthermore, identification of mental strategies which enable individuals to 
reach therapeutic brain states is also required, with the aim being that eventually 
individuals will be able to practice these strategies independent of the feedback 
system after an initial course of training sessions. Whilst, there is a lot of work 
to do, the results so far have been promising, opening window of opportunity to 
manage a number of chronic pain conditions at low cost and without the side effects 
associated with the currently available pharmacological agents.
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